BROS vs RGNX · P/E 105, rev $1.02B vs rev $114.4M
Dutch Bros Inc (BROS) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the BROS and RGNX stock pages for the full models.
Not investment advice.